Dominique J. Dubois
Clinical Instructor
Also affiliated: Cliniques Universitaires Saint-Luc (2004–2025); Université Libre de Bruxelles (2010–2021); Johnson & Johnson (United States) (2004–2010); Janssen (Belgium) (1998–2007); Centre Hospitalier Universitaire de Toulouse (2021); DH Consultancy BVBA (Belgium) (2008–2010); Pfizer (Belgium) (1991); Millennium Engineering and Integration (United States) (2006); Janssen (United States) (2002); Hôpital Charles-Foix (2021–2022); IQ Solutions (2008); Université d'Angers (2001); International Pharmaceutical Federation (2015–2016); Seattle University (2020); UCLouvain (2024)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Dominique J. Dubois' research focuses on patient-reported outcomes and the development and validation of questionnaires to assess quality of life and symptom severity across various health conditions. Dubois has published work on the development of patient-reported outcomes for conditions including constipation, gastroparesis, and upper gastrointestinal disorders. This includes the "Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire" (2005) and the "Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms" (2004).
Further research contributions include an examination of risk factors for chronic constipation and an investigation into the efficacy of laxatives in chronic constipation. Dubois also contributed to a randomized, placebo-controlled trial examining the effect of omega-3 polyunsaturated fatty acid supplementation on cognitive function in elderly adults with memory complaints. Dubois has an h-index of 27, with over 100 publications and 4,506 citations.
Metrics
- h-index: 27
- Publications: 100
- Citations: 4,506
Positions
-
Clinical Instructor 2025–presentUniversity of Arkansas for Medical Sciences College of Nursing ORCID
Selected Publications
-
Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization (2025)
-
Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression (2024)
-
Racial/Ethnic Disparities in Pregnancy-Associated Death: The Critical Importance of Disaggregation by Cause of Death and Race/Ethnicity (2024)
-
P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023 (2024)
-
Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022 (2023)
Collaboration Network
Top Collaborators
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression
- Racial/Ethnic Disparities in Pregnancy-Associated Death: The Critical Importance of Disaggregation by Cause of Death and Race/Ethnicity
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- Association of the COVID-19 Pandemic With Women, Infants, and Children (WIC) Receipt Among Pregnant Individuals: United States, 2016–2022
- P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023
- P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023
- P498: Clinical treatment patterns and outcomes of sickle cell from the Arkansas newborn screening long term follow-up database study: 2011-2023
- Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression
- Impact of the 2022 Infant Formula Shortage on Self-Reported Rates of Anxiety and Depression
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
- Association of Chronic Diabetes with 42-Day Readmission after Delivery Hospitalization
Similar Researchers
Based on overlapping research topics